Last updated: July 24, 2023
Sponsor: Integrative Skin Science and Research
Overall Status: Active - Recruiting
Phase
N/A
Condition
Skin Aging
Treatment
Astaxanthin 6 mg daily
Placebo
Clinical Study ID
NCT05882084
Asta_Skin_01
Ages 30-55 Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion criteria:
- Females who are 30 to 55 years of age
- Half of the women will have Fitzpatrick skin type 1-3 and the other half of the womenwill have Fitzpatrick skin type 4-6
Exclusion
Exclusion criteria:
- Individuals with a known allergy to astaxanthin or other carotenoids (such aszeaxanthin, lutein, lycopene).
- Individuals who are unwilling to discontinue carotenoid supplementation for at least 1month prior to enrollment
- Individuals unwilling to restrict intake of foods like shrimp, salmon, mangos,carrots, and tomatoes during the study.
- New supplementation within 4 weeks with tocopherol
- Individuals who are unwilling to stay consistent with a facial cleansing regimen.
- Those who are unwilling to discontinue topical hydroquinone, retinoid or benzoylperoxide for 2 weeks prior to enrollment
- Individuals who are pregnant or breastfeeding.
- Individuals who have changed any of their hormonal based contraception within 3 monthsprior to joining the study.
- Current tobacco smoker or a tobacco smoking history of greater than 10 pack-years
Study Design
Total Participants: 24
Treatment Group(s): 2
Primary Treatment: Astaxanthin 6 mg daily
Phase:
Study Start date:
July 24, 2023
Estimated Completion Date:
December 31, 2023
Connect with a study center
Integrative Skin Science and Research
Sacramento, California 95819
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.